Yerly S - Search Results

1

HIV Transmission Chains Exhibit Greater HLA-B Homogeneity Than Randomly Expected.

Nguyen H, Thorball CW, Fellay J, Böni J, Yerly S, Perreau M, Klimkait T, Kusejko K, Bachmann N, Chaudron SE, Paioni P, Thurnheer MC, Battegay M, Cavassini M, Vernazza P, Bernasconi E, Günthard HF, Kouyos R; Swiss HIV Cohort Study. Nguyen H, et al. Among authors: yerly s. J Acquir Immune Defic Syndr. 2019 Aug 15;81(5):508-515. doi: 10.1097/QAI.0000000000002077. J Acquir Immune Defic Syndr. 2019. PMID: 31107301 Free article.

2

Early and prolonged decrease of viremia in HIV-1-infected patients treated with didanosine.

Yerly S, Kaiser L, Baumberger C, Hirschel B, Perrin LH. Yerly S, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Apr 1;8(4):358-64. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7882100

3

[Prevalence of transmission of zidovudine-resistant viruses in Switzerland. l'Etude suisse de cohorte VIH].

Yerly S, Rakik A, Kinloch-de-Loes S, Erb P, Vernazza P, Hirschel B, Perrin L. Yerly S, et al. Schweiz Med Wochenschr. 1996 Oct 26;126(43):1845-8. Schweiz Med Wochenschr. 1996. PMID: 9005525 French.

4

Detection of low HIV-1 RNA levels in plasma.

Schockmel GA, Yerly S, Perrin L. Schockmel GA, et al. Among authors: yerly s. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Feb 1;14(2):179-83. doi: 10.1097/00042560-199702010-00013. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9052729

5

Transforming laboratory test results to improve clinical outcome predictions in HIV patients. Swiss HIV Cohort Study.

Perneger TV, Yerly S, Perrin L. Perneger TV, et al. Among authors: yerly s. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Apr 15;17(5):442-9. doi: 10.1097/00042560-199804150-00009. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9562047

6

A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. The Swiss HIV Cohort Study.

Rutschmann OT, Opravil M, Iten A, Malinverni R, Vernazza PL, Bucher HC, Bernasconi E, Sudre P, Leduc D, Yerly S, Perrin LH, Hirschel B. Rutschmann OT, et al. Among authors: yerly s. AIDS. 1998 May 28;12(8):F71-7. doi: 10.1097/00002030-199808000-00003. AIDS. 1998. PMID: 9631134 Clinical Trial.

7

Transmission of antiretroviral-drug-resistant HIV-1 variants.

Yerly S, Kaiser L, Race E, Bru JP, Clavel F, Perrin L. Yerly S, et al. Lancet. 1999 Aug 28;354(9180):729-33. doi: 10.1016/S0140-6736(98)12262-6. Lancet. 1999. PMID: 10475184

8

Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort Study.

Rutschmann OT, Opravil M, Iten A, Malinverni R, Vernazza PL, Bucher H, Bernasconi E, Perrin LH, Yerly S, Hirschel B. Rutschmann OT, et al. Among authors: yerly s. Antivir Ther. 1998;3 Suppl 4:65-7. Antivir Ther. 1998. PMID: 10723515 Clinical Trial.

9

Acute HIV infection: impact on the spread of HIV and transmission of drug resistance.

Yerly S, Vora S, Rizzardi P, Chave JP, Vernazza PL, Flepp M, Telenti A, Battegay M, Veuthey AL, Bru JP, Rickenbach M, Hirschel B, Perrin L; Swiss HIV Cohort Study. Yerly S, et al. AIDS. 2001 Nov 23;15(17):2287-92. doi: 10.1097/00002030-200111230-00010. AIDS. 2001. PMID: 11698702

10

Drug resistance mutations in HIV-1-infected subjects during protease inhibitor-containing highly active antiretroviral therapy with nelfinavir or indinavir.

Yerly S, Rickenbach M, Popescu M, Taffe P, Craig C, Perrin L; Swiss HIV Cohort Study. Yerly S, et al. Antivir Ther. 2001 Sep;6(3):185-9. Antivir Ther. 2001. PMID: 11808753

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

510 results

Search Page